Business Context and Reporting Period
Company: Graham Corporation (NYSE: GHM)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Third quarter and nine months ended December 31, 2025 (Fiscal Year 2026)
Business Overview: Graham designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and advanced mixing technologies for the Defense, Energy & Process, and Space industries. The company operates as a single reporting segment.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $56,701 | $47,037 | $178,215 | $150,551 |
| Gross Profit | $13,469 | $11,686 | $42,496 | $36,853 |
| Gross Margin | 23.8% | 24.8% | 23.8% | 24.5% |
| Operating Income | $3,124 | $2,210 | $12,359 | $9,669 |
| Net Income | $2,845 | $1,588 | $10,530 | $7,835 |
| Diluted EPS | $0.25 | $0.14 | $0.95 | $0.71 |
| Adjusted EBITDA | $6,044 | $4,027 | $19,177 | $14,779 |
| Cash & Equivalents | $22,254 | $21,577 (Mar '25) | $22,254 | $30,046 (Dec '24) |
| Working Capital | $9,145 | $5,222 (Mar '25) | $9,145 | N/A |
| Debt Outstanding | $0 | $0 | $0 | $0 |
Note: Dollar amounts in thousands except per share data. Fiscal year ends March 31.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21% in Q3 and 18% for the nine months ended Dec 31, 2025, compared to the prior year. Defense sales drove a 31% increase in Q3, while Energy & Process sales rose 13%.
- Profitability: Net income surged 79% in Q3 and 34% for the nine-month period. Operating income increased 41% in Q3.
- Margins: Gross margin declined 100 basis points in Q3 to 23.8% due to a mix of sales with lower-margin material receipts and the absence of a $255k BlueForge Alliance grant received in the prior year. SG&A expenses as a percentage of sales improved to 18.6% in Q3 from 20.6% in the prior year.
- Backlog: Total backlog reached a record $515.6 million, a 34% increase year-over-year, driven by strong Defense and Space orders. The book-to-bill ratio for Q3 was 1.3x.
- Acquisitions: Completed the acquisition of Xdot Bearing Technologies in October 2025 ($900k purchase price). Subsequently, on January 23, 2026, acquired FlackTek Manufacturing for $35 million (cash and stock).
Guidance, Outlook, and Risks
Fiscal 2026 Guidance (Updated)
- Net Sales: $233.0 million to $239.0 million (Previous: $225.0M - $235.0M).
- Gross Profit Margin: 24.0% to 25.0% of sales (Previous: 24.5% - 25.5%).
- SG&A Expenses: 17.5% to 18.5% of sales.
- Effective Tax Rate: 16% to 18% (Previous: 20% - 22%).
- Adjusted EBITDA: $24.0 million to $28.0 million (Previous: $22.0M - $28.0M).
- Capital Expenditures: $15.0 million to $18.0 million.
Management Commentary & Risks
- Tariffs: Management estimates the impact of tariffs for the full fiscal year will be an incremental $1.0 million to $1.5 million compared to the prior year.
- Tax Reform: The "One Big Beautiful Bill Act" (OBBB) enacted in July 2025 is expected to increase the effective tax rate by ~200 basis points but will generate approximately $8 million in cash tax savings over two years via bonus depreciation.
- Legal Contingencies: The company faces ongoing asbestos-related lawsuits and is cooperating with authorities regarding a whistleblower investigation into its Indian subsidiary (GIPL). Management does not believe these will have a material adverse effect on financial results.
- Liquidity: The company has a $50 million revolving credit facility (amended to $80 million post-FlackTek acquisition) with no borrowings outstanding as of Dec 31, 2025.
Investor Verification Checklist
- Backlog Conversion: Verify the timing of revenue recognition for the record $515.6 million backlog, noting that 35-40% is expected within one year and the remainder extends beyond two years, heavily weighted toward long-cycle Defense contracts.
- Acquisition Integration: Monitor the integration of Xdot and FlackTek, specifically the realization of synergies and the impact of the $25 million potential earn-out on FlackTek.
- Tariff Exposure: Track the actual impact of tariffs on margins, as management estimates a $1.0M-$1.5M hit for the full year.
- Capital Expenditures: Confirm progress on the $15M-$18M CapEx plan, including the new 30,000 sq. ft. Defense facility and cryogenic testing facility, which are partially funded by customer grants.
- Legal Proceedings: Review updates on the GIPL investigation and asbestos litigation to ensure no material provisions are required.